Published in Clin Infect Dis on January 01, 1992
Transmission of diverse oral bacteria to murine placenta: evidence for the oral microbiome as a potential source of intrauterine infection. Infect Immun (2010) 1.36
Two fatal cases of Veillonella bacteremia. Eur J Clin Microbiol Infect Dis (1998) 1.22
Veillonella parvula discitis and secondary bacteremia: a rare infection complicating endoscopy and colonoscopy? J Clin Microbiol (2006) 1.11
Sepsis caused by Veillonella parvula infection in a 17-year-old patient with X-linked agammaglobulinemia (Bruton's disease). J Clin Microbiol (2006) 0.92
Veillonella parvula bacteremia without an underlying source. J Clin Microbiol (1996) 0.86
Non-vertebral Veillonella species septicemia and osteomyelitis in a patient with diabetes: a case report and review of the literature. J Med Case Rep (2014) 0.85
Receptor recognition of and immune intracellular pathways for Veillonella parvula lipopolysaccharide. Clin Vaccine Immunol (2009) 0.84
Pyogenic sacroiliitis due to Veillonella parvula. Clin Infect Dis (1992) 0.84
Acute pyelonephritis and secondary bacteraemia caused by Veillonella during pregnancy. BMJ Case Rep (2012) 0.84
Contribution of Veillonella parvula to Pseudomonas aeruginosa-mediated pathogenicity in a murine tumor model system. Infect Immun (2014) 0.81
Lytic lesions: looking lethal but leaving room for a simple cure? A case of Veillonella spinal osteomyelitis. JMM Case Rep (2017) 0.75
Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med (2001) 9.08
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med (1996) 6.49
Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med (1991) 5.85
Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med (1993) 4.72
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis (2000) 4.24
Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med (2000) 4.21
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol (2001) 4.19
Legionellosis. N Engl J Med (1997) 4.12
New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 4.04
Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med (1989) 3.98
Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet (1993) 3.89
Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care (1996) 3.70
Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis (1993) 3.68
Ubiquitousness of Legionella pneumophila in the water supply of a hospital with endemic Legionnaires' disease. N Engl J Med (1982) 3.25
Serratia marcescens: historical perspective and clinical review. N Engl J Med (1979) 3.08
Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med (1991) 3.04
Isolation of Legionella pneumophila from hospital shower heads. Ann Intern Med (1981) 2.89
Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. Ann Intern Med (1981) 2.80
Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents (1999) 2.64
Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. J Infect Dis (1998) 2.61
Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med (1986) 2.44
Disease due to the Legionellaceae (other than Legionella pneumophila). Historical, microbiological, clinical, and epidemiological review. Medicine (Baltimore) (1989) 2.31
Evaluation of housestaff physicians' preparation and interpretation of sputum Gram stains for community-acquired pneumonia. J Gen Intern Med (1991) 2.28
Roseomonas, a new genus associated with bacteremia and other human infections. J Clin Microbiol (1993) 2.28
Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature. Rev Infect Dis (1983) 2.27
Diagnosis of Legionnaires' disease. An update of laboratory methods with new emphasis on isolation by culture. JAMA (1983) 2.14
Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med (1996) 2.09
Mode of transmission of Legionella pneumophila. A critical review. Arch Intern Med (1986) 2.04
Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases. J Biol Chem (1995) 2.02
Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis (2007) 1.87
Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrob Agents Chemother (1979) 1.86
Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis (2000) 1.83
Ecology of Legionella pneumophila within water distribution systems. Appl Environ Microbiol (1985) 1.83
Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med (1986) 1.81
Comparison of molecular methods for subtyping patients and epidemiologically linked environmental isolates of Legionella pneumophila. J Infect Dis (1988) 1.80
Epidemiologic perspectives on Enterobacter for the infection control professional. Am J Infect Control (1994) 1.78
In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans. Antimicrob Agents Chemother (1995) 1.77
A pink-pigmented, oxidative, nonmotile bacterium as a cause of opportunistic infections. Arch Intern Med (1989) 1.73
Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new). Antimicrob Agents Chemother (1980) 1.62
Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med (1995) 1.59
High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial. Ann Intern Med (1994) 1.59
Antimicrobial selection by a computer. A blinded evaluation by infectious diseases experts. JAMA (1979) 1.56
Manual of culture methodology for Legionella. Semin Respir Infect (1987) 1.54
Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. Arch Intern Med (1987) 1.53
Extended-spectrum beta-lactamases: a call for improved detection and control. Clin Infect Dis (1999) 1.53
Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis. Arch Otolaryngol Head Neck Surg (1989) 1.50
Beta-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease. Am J Med (1993) 1.46
Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia. Am J Med (1992) 1.46
Listeria monocytogenes peritonitis in cirrhotic patients. Value of ascitic fluid gram stain and a review of literature. Dig Dis Sci (1994) 1.43
Potable water as a cause of sporadic cases of community-acquired legionnaires' disease. N Engl J Med (1992) 1.43
Role of aerobic gram-negative rods, anaerobes, and fungi in wound infection after head and neck surgery: implications for antibiotic prophylaxis. Head Neck (1989) 1.41
Protecting tomorrow's health care professionals against hepatitis B virus today. Arch Intern Med (1991) 1.40
Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Clin Infect Dis (1996) 1.38
Isolation of Pittsburgh pneumonia agent from nebulizers used in respiratory therapy. Ann Intern Med (1980) 1.36
Clinical demonstration of isolation of Nocardia asteroides on buffered charcoal-yeast extract media. J Clin Microbiol (1992) 1.36
Legionnaires' disease: new clinical perspective from a prospective pneumonia study. Am J Med (1982) 1.34
Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med (1999) 1.32
Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology (1994) 1.32
In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother (1996) 1.29
MYCIN II: design and implementation of a therapy reference with complex content-based indexing. Proc AMIA Symp (1998) 1.28
Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis (1995) 1.28
Efficacy of two third-generation cephalosporins in prophylaxis for head and neck surgery. Arch Otolaryngol (1984) 1.25
Legionnaires' disease acquired within the homes of two patients. Link to the home water supply. JAMA (1987) 1.25
Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation (1997) 1.23
Potable water supply as the hospital reservoir for Pittsburgh pneumonia agent. Lancet (1982) 1.22
Comparative assessment of chlorine, heat, ozone, and UV light for killing Legionella pneumophila within a model plumbing system. Appl Environ Microbiol (1987) 1.22
Human acetyltransferase polymorphisms. Mutat Res (1997) 1.21
New antimicrobial agents as therapy for resistant gram-positive cocci. Eur J Clin Microbiol Infect Dis (2008) 1.21
Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med (1988) 1.21
Growth of 28 Legionella species on selective culture media: a comparative study. J Clin Microbiol (1993) 1.19
Pneumonia due to the Pittsburgh pneumonia agent: new clinical perspective with a review of the literature. Medicine (Baltimore) (1983) 1.17
Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management. Medicine (Baltimore) (1994) 1.17
Synergy assessed by checkerboard. A critical analysis. Diagn Microbiol Infect Dis (1993) 1.16
Measurement of serum and tissue concentration of moxalactam using high pressure liquid chromatography. Ther Drug Monit (1981) 1.16
Potential in-hospital modes of transmission of Legionella pneumophila. Demonstration experiments for dissemination by showers, humidifiers, and rinsing of ventilation bag apparatus. Am J Med (1986) 1.15
Cefamandole-susceptible strains of Legionella pneumophila serogroup 1: implications for diagnosis and utility as an epidemiological marker. J Clin Microbiol (1992) 1.14
Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia. J Infect Dis (1980) 1.14
Determinants of Legionella pneumophila contamination of water distribution systems: 15-hospital prospective study. Infect Control (1987) 1.14
A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res (1996) 1.13
Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis. Arch Intern Med (1989) 1.13
Malignant external otitis: utility of CT in diagnosis and follow-up. Radiology (1990) 1.13
Can Legionnaires disease be diagnosed by clinical criteria? A critical review. Chest (2001) 1.10
Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control (1992) 1.10
Pseudomonas stutzeri bacteremia associated with hemodialysis. Arch Intern Med (1983) 1.10
Staphylococcus lugdunensis endocarditis--the hidden peril of coagulase-negative staphylococcus in blood cultures. Eur J Clin Microbiol Infect Dis (2003) 1.08
Determinants of nontraditional therapy use in patients with HIV infection. A prospective study. Arch Intern Med (1996) 1.08
Legionella pneumophila in residential water supplies: environmental surveillance with clinical assessment for Legionnaires' disease. Epidemiol Infect (1992) 1.07
A mechanism of rifamycin inhibition and resistance in Pseudomonas aeruginosa. J Antimicrob Chemother (1996) 1.06
Sino-orbital aspergillosis treated with combination antifungal therapy. Successful therapy after failure with amphotericin B and surgery. JAMA (1980) 1.05
Evaluating the performance of a computer-based consultant. Comput Programs Biomed (1979) 1.04
Prognosis of patients hospitalized with community-acquired pneumonia. Am J Med (1990) 1.04
Legionnaires' disease contracted from patient homes: the coming of the third plague? Eur J Clin Microbiol Infect Dis (2002) 1.04
Susceptibility of members of the family Legionellaceae to thermal stress: implications for heat eradication methods in water distribution systems. Appl Environ Microbiol (1986) 1.03
An assessment of the need for gram-negative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgery. J Infect Dis (1987) 1.03
Legionella as a cause of severe pneumonia. Semin Respir Crit Care Med (2000) 1.02
Patient factors contributing to the emergence of gentamicin-resistant Serratia marcescens. Am J Med (1979) 1.02
Could aspiration be the major mode of transmission for Legionella? Am J Med (1993) 1.02
Unexpected similarity of pulsed-field gel electrophoresis patterns of unrelated clinical isolates of Legionella pneumophila, serogroup 1. J Infect Dis (2001) 1.02
Factors predisposing to Legionella pneumophila colonization in residential water systems. Arch Environ Health (1988) 1.02